ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: PP03

Bridging the Gap: Leveraging Social Media to Improve Patient Support; Build a Path to Collaborative Medicine

Carlene Harrison1 and Tiffany Peterson 1, 1Lupus and Allied Diseases Association, Inc.

Meeting: 2019 ACR/ARP Annual Meeting

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 10, 2019

Title: Patient Perspectives Poster Session

Session Type: Poster Session (Sunday)

Session Time: 11:30AM-1:30PM

Background/Purpose: Due to the heterogeneous nature of disease presentation, when diagnosed with Systemic Lupus Erythematosus (SLE) patients often experience overwhelming feelings of isolation. This comes as a result of not knowing there are others, that may be experiencing the same types of symptoms. These sentiments proved true for two patients living six hours apart who would come to meet years later through their individual quests to attain more knowledge about SLE and find support from others facing the same challenges they met daily. Both Carly and Tiffany, patients diagnosed with SLE and secondary illnesses including Raynaud’s Phenomenon, Fibromyalgia, and Nephritis within a year of each other, would come to connect years later through an online patient led community.

After spending years in search of resources for patients, Tiffany founded the online community #LupusChat to offer educational information about SLE to patients and provide a safe space for patients to feel supported. Through the years the community grew to include patients, advocates, physicians, scientists, industry leaders, and other partners in healthcare.

Treatment: SLE patients are treated with traditional interventions including immunosuppressants, corticosteroids, and antimalarials. Considerations are oftentimes only made in terms of treating the physical symptoms of the disease. This approach doesn’t typically account for mental or emotional complications associated with SLE. This leads to a disconnect between patients and healthcare professionals, where patients feel physicians aren’t empathetic to their needs outside of lab results and physicians complain of low treatment adherence and lack of interest in the patient’s own medical care. Through online discussions with topics ranging from interpreting lab test results and connecting with doctors to becoming advocates, #LupusChat works to connect all healthcare stakeholders.

Maintenance: Both Tiffany and Carly found solace through the connections made from this online community. Starting out as solely a member of the community, Carly now joins Tiffany and two other Patient Advocates in curating discussions and sharing health literacy tools with the chronic illness community. They also work with groups like the patient founded national non-profit organization, Lupus and Allied Diseases Association, Inc. (LADA) on advocacy initiatives. This includes working with legislators at the state and federal level, attending and speaking at conferences, and educating patients on the importance of clinical trial participation.

Quality of Life: These patients have not only become advocates themselves, but have helped others to become empowered. Their roles in the Lupus community have also led them to become more adherent to their own treatment plans. They receive testimonials from other patients about the impact the community has had on their lives and how things like daily community medication reminders have impacted their health. Healthcare professionals have also become more involved in patient outreach and often seek their assistance in learning to use social media as a tool to educate patients. Through social media engagement, they amplify the Patient voice and help foster healthcare partnerships.

Maintenance

Patient advocates and community managers

Quality of Life

Statistical graphic showing the engagement impact and reach of just one community discussion


Disclosure: C. Harrison, Aurinia Pharmaceuticals Inc, 5; T. Peterson, Aurinia Pharmaceuticals Inc, 5.

To cite this abstract in AMA style:

Harrison C, Peterson T. Bridging the Gap: Leveraging Social Media to Improve Patient Support; Build a Path to Collaborative Medicine [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/bridging-the-gap-leveraging-social-media-to-improve-patient-support-build-a-path-to-collaborative-medicine/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/bridging-the-gap-leveraging-social-media-to-improve-patient-support-build-a-path-to-collaborative-medicine/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology